Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
Clinical trial NCT00088283 · COMPLETED
Trial details
- NCT number
- NCT00088283
- Sponsor
- Eyetech Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.